Campaigners against the UK’s controversial drug pricing deal with Donald Trump are threatening the government with legal action unless it scraps a key element of the plan.
They claim that a change to how drug treatments are approved for use by the NHS, which could lead to it paying even higher prices for them, amounts to an “unlawful power grab”.
